Detection rate of IGF-1 variants and their implication to protein binding: study of over 240,000 patients.

To determine the detection rate of IGF-1 variants in a clinical population and assess their implications. IGF-1 variants were detected based on their predicted mass-to-charge ratios. Most variants were distinguished by their isotopic distribution and relative retention times. A67T and A70T were distinguished with MS/MS. Patient specimens with a detected variant were de-identified for DNA sequencing to confirm the polymorphism. Of the 243,808 patients screened, 1,099 patients containing IGF-1 variants were identified (0.45 %, or 4,508 occurrences per million). Seven patients were identified as homozygous or double heterozygous. Majority of variants (98 %) had amino acid substitutions located at the C-terminus (A62T, P66A, A67S, A67V, A67T, A70T). Isobaric variants A38V and A67V were detected more frequently in children than in adults. Six previously unreported variants were identified: Y31H, S33P, T41I, R50Q, R56K, and A62T. Compared with the overall population, z-score distribution of patients with IGF-1 variants was shifted toward negative levels (median z-score -1.4); however, it resembled the overall population when corrected for heterozygosity. Chromatographic peak area of some variants differed from that of the WT IGF-1 present in the same patient. In the IGF-1 test reports by LC-MS, the concentrations only account for half the total IGF-1 for patients with heterozygous IGF-1 variants. An IGF-1 variant may change the binding to its receptor and/or its binding proteins, affecting its activity and half-life in circulation. Variants located in or close to the C-domain may be pathogenic. Cross-species sequence comparison indicates that A38V and A70T may have some degree of pathogenicity. © 2023 the author(s), published by De Gruyter, Berlin/Boston.

Citation

Ievgen Motorykin, Jianying Mu, Bradley S Miller, Allison Li, Nigel J Clarke, Michael J McPhaul, Zengru Wu. Detection rate of IGF-1 variants and their implication to protein binding: study of over 240,000 patients. Clinical chemistry and laboratory medicine. 2024 Feb 26;62(3):484-492

Mesh Tags

Substances

PMID: 37811857

search → result